Cargando…
Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study
The urinary tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 ([TIMP-2]∙[IGFBP7]) have been introduced to improve risk prediction of severe acute kidney injury (AKI) within 12 hours of measurement. We performed a prospective cohort study to evaluate if the pre...
Autores principales: | Ferrari, Fiorenza, Romero-González, Gregorio, Topete, Lilia Rizo, Senzolo, Mara, Lorenzin, Anna, Husain-Syed, Faeq, Puci, Mariangela Valentina, Ferraro, Ottavia Eleonora, Muraro, Eva, Serrano-Soto, Mara, Triviño, Alejandra Molano, Castro, Ana Coutinho, Xie, Yun, Yang, Bo, De Cal, Massimo, Corradi, Valentina, Brendolan, Alessandra, Scarpa, Marta, Carta, Maria Rosa, Giavarina, Davide, Bonato, Raffaele, Ronco, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848119/ https://www.ncbi.nlm.nih.gov/pubmed/31712687 http://dx.doi.org/10.1038/s41598-019-52790-6 |
Ejemplares similares
-
Development and validation of quick Acute Kidney Injury-score (q-AKI) to predict acute kidney injury at admission to a multidisciplinary intensive care unit
por: Ferrari, Fiorenza, et al.
Publicado: (2019) -
Routine Adoption of TIMP2 and IGFBP7 Biomarkers in Cardiac Surgery for Early Identification of Acute Kidney Injury
por: Levante, Chiara, et al.
Publicado: (2018) -
Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients
por: Godi, Ilaria, et al.
Publicado: (2020) -
Incidence of Acute Kidney Injury in Polytrauma Patients and Predictive Performance of TIMP2 × IGFBP7 Biomarkers for Early Identification of Acute Kidney Injury
por: Golino, Gianlorenzo, et al.
Publicado: (2022) -
Prospective, Randomized, Multicenter, Controlled Trial (TRIATHRON 1) on a New Antithrombogenic Hydrophilic Dialysis Membrane
por: Ronco, Claudio, et al.
Publicado: (2018)